Reevaluating Liposomal Bupivacaine: Insights and Implications for Canine Pain Management

Send us Fan MailJoin us as Drs. Vanna Dickerson and Danielle Hollenbeck discuss the impact of peri-incisional liposomal bupivacaine on postoperative pain scores, opioid use after soft tissue surgeries, and incidence of incision site complications in dogs. Despite its widespread use, liposomal bupivacaine may not be providing the pain relief many expect. With 83 dogs enrolled in their study, these findings challenge the status quo in veterinary medicine, emphasizing the importance of evidence-based care and cost-effectiveness. These revelations could reshape clinical practices, especially in cases where traditional analgesics fall short. Explore the nuances of their study and the broader implications for veterinarians striving to enhance patient outcomes.JAVMA article: https://doi.org/10.2460/javma.24.09.0589INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?JAVMA ® : https://avma.org/JAVMAAuthorsAJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® :Facebook: Journal of the American Veterinary Medical Association - JAVMA | FacebookInstagram: JAVMA (@avma_javma) • Instagram photos and videosTwitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | FacebookInstagram: AJVR (@ajvroa) • Instagram photos and videosTwitter: AJVR (@AJVROA) / TwitterJAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals